Loading…
Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation
It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the...
Saved in:
Published in: | Human reproduction (Oxford) 1998-10, Vol.13 (10), p.2926-2932 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63 |
---|---|
cites | |
container_end_page | 2932 |
container_issue | 10 |
container_start_page | 2926 |
container_title | Human reproduction (Oxford) |
container_volume | 13 |
creator | Fong, C Y Bongso, A Ng, S C Kumar, J Trounson, A Ratnam, S |
description | It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation. |
doi_str_mv | 10.1093/humrep/13.10.2926 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70037849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/13.10.2926</oup_id><sourcerecordid>70037849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63</originalsourceid><addsrcrecordid>eNqNkE9v3CAQxVHVKtn8-QA9ROJQ9RQnDLDY7i2N0iZSpF6SszWLoaGywQUcafecDx42u8o5Fxh4v3kwj5CvwC6AteLyaR6jmS5BlOMFb7n6RBYgFau4WLLPZMG4aioABYfkKKV_jJWyUQfkoG2Y5Mt6QV5-Dphy0OuUaY7okzWRos1lNX6zHjE7XQSDeTQ-02BpfjJ0EzzSyQzDrF2PP6gbpxienf9Lna-eXY6BFp_sBrcpBsFT9D2dfW9iyqV8A8dpQJ_f5BPyxeKQzOl-PyaPv24erm-r-z-_766v7ista8iVqVvb2Jo1RoBtl4KXaWq5UrVuccWl0GBBAhgtG9HznhVIWFBScsZQoxLH5PvOt_z2_2xS7kaXdBkDvQlz6mrGRN3ItoCwA3UMKUVjuym6EeO6A9Ztk-92yXcgtjfb5EvP2d58Xo2mf-_YR130b3sdk8bBlrC1S-8YLxAoXrDzHRbm6QOvvgKSC57m</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70037849</pqid></control><display><type>article</type><title>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</title><source>Oxford Journals Online</source><creator>Fong, C Y ; Bongso, A ; Ng, S C ; Kumar, J ; Trounson, A ; Ratnam, S</creator><creatorcontrib>Fong, C Y ; Bongso, A ; Ng, S C ; Kumar, J ; Trounson, A ; Ratnam, S</creatorcontrib><description>It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.</description><identifier>ISSN: 0268-1161</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/13.10.2926</identifier><identifier>PMID: 9804257</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Birth control ; Blastocyst - drug effects ; Blastocyst - physiology ; Embryo Implantation - drug effects ; Embryo Implantation - physiology ; Embryo Transfer - adverse effects ; Embryo Transfer - methods ; Female ; Fertilization in Vitro ; Gynecology. Andrology. Obstetrics ; Humans ; In Vitro Techniques ; Infertility - therapy ; Male ; Medical sciences ; Pregnancy ; Pregnancy Rate ; Pregnancy, Multiple ; Pronase - pharmacology ; Prospective Studies ; Safety ; Sterility. Assisted procreation ; Zona Pellucida - drug effects ; Zona Pellucida - physiology</subject><ispartof>Human reproduction (Oxford), 1998-10, Vol.13 (10), p.2926-2932</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2425162$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9804257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fong, C Y</creatorcontrib><creatorcontrib>Bongso, A</creatorcontrib><creatorcontrib>Ng, S C</creatorcontrib><creatorcontrib>Kumar, J</creatorcontrib><creatorcontrib>Trounson, A</creatorcontrib><creatorcontrib>Ratnam, S</creatorcontrib><title>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</title><title>Human reproduction (Oxford)</title><addtitle>Hum Reprod</addtitle><addtitle>Hum Reprod</addtitle><description>It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Blastocyst - drug effects</subject><subject>Blastocyst - physiology</subject><subject>Embryo Implantation - drug effects</subject><subject>Embryo Implantation - physiology</subject><subject>Embryo Transfer - adverse effects</subject><subject>Embryo Transfer - methods</subject><subject>Female</subject><subject>Fertilization in Vitro</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Infertility - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Pregnancy, Multiple</subject><subject>Pronase - pharmacology</subject><subject>Prospective Studies</subject><subject>Safety</subject><subject>Sterility. Assisted procreation</subject><subject>Zona Pellucida - drug effects</subject><subject>Zona Pellucida - physiology</subject><issn>0268-1161</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNkE9v3CAQxVHVKtn8-QA9ROJQ9RQnDLDY7i2N0iZSpF6SszWLoaGywQUcafecDx42u8o5Fxh4v3kwj5CvwC6AteLyaR6jmS5BlOMFb7n6RBYgFau4WLLPZMG4aioABYfkKKV_jJWyUQfkoG2Y5Mt6QV5-Dphy0OuUaY7okzWRos1lNX6zHjE7XQSDeTQ-02BpfjJ0EzzSyQzDrF2PP6gbpxienf9Lna-eXY6BFp_sBrcpBsFT9D2dfW9iyqV8A8dpQJ_f5BPyxeKQzOl-PyaPv24erm-r-z-_766v7ista8iVqVvb2Jo1RoBtl4KXaWq5UrVuccWl0GBBAhgtG9HznhVIWFBScsZQoxLH5PvOt_z2_2xS7kaXdBkDvQlz6mrGRN3ItoCwA3UMKUVjuym6EeO6A9Ztk-92yXcgtjfb5EvP2d58Xo2mf-_YR130b3sdk8bBlrC1S-8YLxAoXrDzHRbm6QOvvgKSC57m</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Fong, C Y</creator><creator>Bongso, A</creator><creator>Ng, S C</creator><creator>Kumar, J</creator><creator>Trounson, A</creator><creator>Ratnam, S</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981001</creationdate><title>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</title><author>Fong, C Y ; Bongso, A ; Ng, S C ; Kumar, J ; Trounson, A ; Ratnam, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Blastocyst - drug effects</topic><topic>Blastocyst - physiology</topic><topic>Embryo Implantation - drug effects</topic><topic>Embryo Implantation - physiology</topic><topic>Embryo Transfer - adverse effects</topic><topic>Embryo Transfer - methods</topic><topic>Female</topic><topic>Fertilization in Vitro</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Infertility - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Pregnancy, Multiple</topic><topic>Pronase - pharmacology</topic><topic>Prospective Studies</topic><topic>Safety</topic><topic>Sterility. Assisted procreation</topic><topic>Zona Pellucida - drug effects</topic><topic>Zona Pellucida - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fong, C Y</creatorcontrib><creatorcontrib>Bongso, A</creatorcontrib><creatorcontrib>Ng, S C</creatorcontrib><creatorcontrib>Kumar, J</creatorcontrib><creatorcontrib>Trounson, A</creatorcontrib><creatorcontrib>Ratnam, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fong, C Y</au><au>Bongso, A</au><au>Ng, S C</au><au>Kumar, J</au><au>Trounson, A</au><au>Ratnam, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum Reprod</stitle><addtitle>Hum Reprod</addtitle><date>1998-10-01</date><risdate>1998</risdate><volume>13</volume><issue>10</issue><spage>2926</spage><epage>2932</epage><pages>2926-2932</pages><issn>0268-1161</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>It has been shown recently that delayed transfers improve implantation rates in assisted reproductive technology programmes. In a prospective study, the pregnancy rates and safety of outcome were evaluated in a group of patients after the transfer of day 5 blastocysts with enzymatic treatment of the zona pellucida. Nineteen women with a mean age of 32.6+/-5.2 years and mean 2.1+/-2.2 repeated attempts had blastocyst transfers with a mean number of 2.5+/-0.7 embryos replaced per patient. The clinical pregnancy rates per cycle/transfer and implantation rate were 53% and 33%, respectively. The multiple pregnancy rate was 40% (two pregnancies were triplets). The pregnancy and implantation rates were very much higher than observed for most assisted reproduction technology centres. The 'in-vitro implantation' rates of zona-free blastocysts on a variety of feeder monolayers was 92%, offering some thoughts as to the role of the zona and interaction of the inner cell mass and trophoectoderm with the endometrium in implantation. Based on the in-vitro studies and the high multiple pregnancy rates, it appears that zona-manipulated blastocysts implant relatively well and there would be a need to reduce the number of transferred embryos to one or two, thus reducing multiple pregnancies and having spare blastocysts available for cryopreservation. The results also suggest that using the embryo culture protocol and method of transfer in the present study offers encouraging improvements to assisted reproduction technology, and enzymatic treatment of the zona may allow better anchorage and dialogue of the embryo with the endometrium, helping us to improve and understand implantation.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>9804257</pmid><doi>10.1093/humrep/13.10.2926</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0268-1161 |
ispartof | Human reproduction (Oxford), 1998-10, Vol.13 (10), p.2926-2932 |
issn | 0268-1161 1460-2350 |
language | eng |
recordid | cdi_proquest_miscellaneous_70037849 |
source | Oxford Journals Online |
subjects | Adult Biological and medical sciences Birth control Blastocyst - drug effects Blastocyst - physiology Embryo Implantation - drug effects Embryo Implantation - physiology Embryo Transfer - adverse effects Embryo Transfer - methods Female Fertilization in Vitro Gynecology. Andrology. Obstetrics Humans In Vitro Techniques Infertility - therapy Male Medical sciences Pregnancy Pregnancy Rate Pregnancy, Multiple Pronase - pharmacology Prospective Studies Safety Sterility. Assisted procreation Zona Pellucida - drug effects Zona Pellucida - physiology |
title | Blastocyst transfer after enzymatic treatment of the zona pellucida: improving in-vitro fertilization and understanding implantation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A58%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blastocyst%20transfer%20after%20enzymatic%20treatment%20of%20the%20zona%20pellucida:%20improving%20in-vitro%20fertilization%20and%20understanding%20implantation&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Fong,%20C%20Y&rft.date=1998-10-01&rft.volume=13&rft.issue=10&rft.spage=2926&rft.epage=2932&rft.pages=2926-2932&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/13.10.2926&rft_dat=%3Cproquest_cross%3E70037849%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-e79f8f708e31f953216174b67c9ab243c1f1411ec483d2d01f93f1644200aca63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70037849&rft_id=info:pmid/9804257&rft_oup_id=10.1093/humrep/13.10.2926&rfr_iscdi=true |